Logo
Secure Registration

International Conference on Genetic Disorders and Molecular Pathogenesis

ICGDAMP

4th Nov – 5th Nov 2026 Bago, Burma

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Read the full Terms & Conditions

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 10
01 Molecular Mechanisms of Genetic Disorders +
This session will explore the underlying molecular mechanisms that contribute to various genetic disorders. Emphasis will be placed on the role of mutations and their impact on cellular pathways.
SDG 3 SDG 4
02 Advancements in Genetic Screening Techniques +
This track will focus on the latest advancements in genetic screening methodologies, including next-generation sequencing and bioinformatics approaches. Participants will discuss the implications of these technologies for early diagnosis and intervention.
SDG 3 SDG 9
03 Genotype-Phenotype Correlations in Monogenic Disorders +
This session aims to elucidate the genotype-phenotype relationships in monogenic disorders, highlighting case studies and recent findings. Discussions will center on how these correlations inform clinical practice and patient management.
SDG 3 SDG 4
04 Polygenic Risk Scores and Complex Diseases +
This track will delve into the development and application of polygenic risk scores in understanding complex diseases. Presentations will cover methodologies for assessing genetic risk and their implications for precision medicine.
SDG 3 SDG 9
05 Rare Disease Genomics: Challenges and Innovations +
This session will address the unique challenges faced in the genomics of rare diseases, including diagnostic odysseys and therapeutic avenues. Innovations in genomic technologies and collaborative research efforts will be highlighted.
SDG 3 SDG 10
06 Pathogenic Variants: Identification and Characterization +
This track will focus on the identification and characterization of pathogenic variants associated with genetic disorders. Participants will discuss methodologies for variant interpretation and their clinical significance.
SDG 3 SDG 9
07 Molecular Pathways in Disease Mechanisms +
This session will explore the molecular pathways implicated in various genetic disorders and their role in disease mechanisms. Insights into therapeutic targets and intervention strategies will be discussed.
SDG 3 SDG 10
08 Clinical Genetics and Patient Management +
This track will examine the role of clinical genetics in the management of hereditary conditions. Topics will include genetic counseling, risk assessment, and the integration of genomic data into clinical practice.
SDG 3 SDG 4
09 Disease Biomarkers in Genetic Disorders +
This session will explore the identification and validation of disease biomarkers in genetic disorders. Emphasis will be placed on their potential for improving diagnosis, prognosis, and treatment strategies.
SDG 3 SDG 9
10 Functional Genomics in Disease Research +
This track will focus on the application of functional genomics in understanding the biological basis of genetic disorders. Discussions will include experimental approaches and their relevance to therapeutic development.
SDG 3 SDG 10
11 Genomic Medicine: Transforming Healthcare +
This session will highlight the transformative potential of genomic medicine in healthcare delivery. Topics will include personalized treatment strategies, ethical considerations, and the future of genomics in clinical settings.
SDG 3 SDG 9